Through our continued collaboration with a leading pathology laboratory and a leading genomic service provider, SGS. can facilitate the collection of skin biopsies and the subsequent analysis of various biomarker endpoints. The incorporation of biomarker analysis into clinical trials can provide Sponsors with a better understanding of the mechanism of action that underlies the effects associated with a treatment product or even a single ingredient. As an example, SGS has been able to document the in vivo antioxidant effects of a topical treatment product.
Anti-oxidant protected site
Thymine dimers-unprotected UV site from UV exposure